Predictors of methotrexate adherence and patient's awareness of it in rheumatoid arthritis and its effect on quality of life

References

• Ahmed, Q., Talha, M., Ishtiaq, U., Khurshid, S., Akbar, K., Amir, U., … Akbar, Z. (2023). Quality of life and medication adherence in rheumatoid arthritis patients. Mathews Journal of Pharmaceutical Science, 7(4), 1–9. https://doi.org/10.30654/MJPS.10024
   Google Scholar
• Albrecht, K., & M ler-Ladner, U. (2010). Side effects and management of side effects of methotrexate in rheumatoid arthritis. Clinical and Experimental Rheumatology-Incl Supplements, 28(5), S95.
   PubMed Web of Science ®Google Scholar
• Aletaha, D., & Smolen, J. S. (2002). Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational study. The Journal of Rheumatology, 29(8), 1631–1638.
   PubMed Web of Science ®Google Scholar
• Bernatsky, S., & Feldman, D. E. (2008). Discontinuation of methotrexate therapy in older patients with newly diagnosed rheumatoid arthritis. Drugs & Aging, 25(10), 879–884. https://doi.org/10.2165/00002512-200825100-00007
   PubMed Web of Science ®Google Scholar
• Bruce, B., & Fries, J. F. (2003). The Stanford Health Assessment Questionnaire: Dimensions and practical applications. Health and Quality of Life Outcomes, 1(1), 20–26. https://doi.org/10.1186/1477-7525-1-20
   PubMedGoogle Scholar
• Brus, H., van de Laar, M., Taal, E., Rasker, J., & Wiegman, O. (1999). Determinants of compliance with medication in patients with rheumatoid arthritis: The importance of self-efficacy expectations. Patient Education and Counseling, 36(1), 57–64. https://doi.org/10.1016/S0738-3991(98)00087-1
   PubMed Web of Science ®Google Scholar
• Ceranic, J., Kisic Tepavcevic, D., Petronijevic, M., Milic, M., Ceranic, M., Rancic, N., & Ristic, G. (2023). Assessment and prediction of adherence to methotrexate using three self-report questionnaires in patients with rheumatoid arthritis. Medicina, 59(8), 1446. https://doi.org/10.3390/medicina59081446
   PubMedGoogle Scholar
• Chen, C.-W., Walter, P., & Wei, J. C.-C. (2024). Using ChatGPT-like solutions to bridge the communication gap between patients with rheumatoid arthritis and health care professionals. JMIR Medical Education, 10, e48989. https://doi.org/10.2196/48989
   PubMedGoogle Scholar
• Curtis, J. R., Bykerk, V. P., Aassi, M., & Schiff, M. (2016). Adherence and persistence with methotrexate in rheumatoid arthritis: A systematic review. The Journal of Rheumatology, 43(11), 1997–2009. https://doi.org/10.3899/jrheum.151212
   PubMed Web of Science ®Google Scholar
• de Klerk, E., Van der Heijde, D., Landewé, R., Van der Tempel, H., & Van der Linden, S. (1999). Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy. The Journal of Rheumatology, 26(12), 2635–2641.
   PubMed Web of Science ®Google Scholar
• de Klerk, E., van der Heijde, D., Landewé, R., van der Tempel, H., & van der Linden, S. (2003a). The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: A validation study. The Journal of Rheumatology, 30(11), 2469–2475.
   PubMed Web of Science ®Google Scholar
• de Klerk, E., van der Heijde, D., Landewé, R., van der Tempel, H., & van der Linden, S. (2003b). Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout. The Journal of Rheumatology, 30(1), 44–54.
   PubMed Web of Science ®Google Scholar
• de Thurah, A., Nørgaard, M., Harder, I., & Stengaard-Pedersen, K. (2010). Compliance with methotrexate treatment in patients with rheumatoid arthritis: Influence of patients’ beliefs about the medicine. A prospective cohort study. Rheumatology International, 30(11), 1441–1448. https://doi.org/10.1007/s00296-009-1160-8
   PubMed Web of Science ®Google Scholar
• DiBenedetti, D. B., Zhou, X., Reynolds, M., Ogale, S., & Best, J. H. (2015). Assessing methotrexate adherence in rheumatoid arthritis: A cross-sectional survey. Rheumatology and Therapy, 2(1), 73–84. https://doi.org/10.1007/s40744-015-0011-1
   PubMedGoogle Scholar
• Dunbar-Jacob, J., Holmes, J. L., Sereika, S., Kwoh, C. K., Burke, L. E., Starz, T. W., McCall, M., & Foley, S. M. (2004). Factors associated with attrition of African Americans during the recruitment phase of a clinical trial examining adherence among individuals with rheumatoid arthritis. Arthritis Care & Research, 51(3), 422–428. https://doi.org/10.1002/art.20411
   Web of Science ®Google Scholar
• Fayet, F., Savel, C., Rodere, M., Pereira, B., Abdi, D., Mathieu, S., Tournadre, A., Soubrier, M., & Dubost, J. (2016). The development of a questionnaire to evaluate rheumatoid arthritis patient's knowledge about methotrexate. Journal of Clinical Nursing, 25(5-6), 682–689. https://doi.org/10.1111/jocn.12999
   PubMed Web of Science ®Google Scholar
• Finckh, A., Gilbert, B., Hodkinson, B., Bae, S.-C., Thomas, R., Deane, K. D., Alpizar-Rodriguez, D., & Lauper, K. (2022). Global epidemiology of rheumatoid arthritis. Nature Reviews Rheumatology, 18(10), 591–602. https://doi.org/10.1038/s41584-022-00827-y
   PubMed Web of Science ®Google Scholar
• Fries, J. F., Spitz, P., Kraines, R. G., & Holman, H. R. (1980). Measurement of patient outcome in arthritis. Arthritis & Rheumatism, 23(2), 137–145. https://doi.org/10.1002/art.1780230202
   PubMed Web of Science ®Google Scholar
• Gadallah, M. A., Boulos, D. N., Dewedar, S., Gebrel, A., & Morisky, D. E. (2015). Assessment of rheumatoid arthritis patients’ adherence to treatment. The American Journal of the Medical Sciences, 349(2), 151–156. https://doi.org/10.1097/MAJ.0000000000000376
   PubMed Web of Science ®Google Scholar
• Geoffroy, M., Gozalo, C., Konecki, C., Pauvele, L., Hittinger, A., Theate, N., Feliu, C., Salmon, J. H., & Djerada, Z. (2023). A new pharmacokinetic model of urinary methotrexate to assess adherence in rheumatoid arthritis. Biomedicine & Pharmacotherapy, 168, 115620. https://doi.org/10.1016/j.biopha.2023.115620
   PubMed Web of Science ®Google Scholar
• Gong, G., & Mao, J. (2016). Health-related quality of life among Chinese patients with rheumatoid arthritis. Nursing Research, 65(1), 55–67. https://doi.org/10.1097/NNR.0000000000000137
   PubMed Web of Science ®Google Scholar
• Häkkinen, A., Kautiainen, H., Hannonen, P., Ylinen, J., Arkela-Kautiainen, M., & Sokka, T. (2005). Pain and joint mobility explain individual subdimensions of the health assessment questionnaire (HAQ) disability index in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 64(1), 59–63. https://doi.org/10.1136/ard.2003.019935
   PubMed Web of Science ®Google Scholar
• Haroon, N., Aggarwal, A., Lawrence, A., Agarwal, V., & Misra, R. (2007). Impact of rheumatoid arthritis on quality of life. Modern Rheumatology, 17(4), 290–295. https://doi.org/10.3109/s10165-007-0604-9
   PubMedGoogle Scholar
• Harrold, L. R., & Andrade, S. E. (2009). Medication adherence of patients with selected rheumatic conditions: A systematic review of the literature. Seminars in Arthritis and Rheumatism, 38(5), 396–402. https://doi.org/10.1016/j.semarthrit.2008.01.011.
   Google Scholar
• Hoekstra, M., van de Laar, M. A., Moens, H. J. B., Kruijsen, M. W., & Haagsma, C. J. (2003). Longterm observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis. The Journal of Rheumatology, 30(11), 2325–2329.
   PubMed Web of Science ®Google Scholar
• Hope, H. F., Bluett, J., Barton, A., Hyrich, K. L., Cordingley, L., & Verstappen, S. M. (2016). Psychological factors predict adherence to methotrexate in rheumatoid arthritis; findings from a systematic review of rates: Predictors and associations with patient-reported and clinical outcomes. RMD Open, 2(1), e000171. http://orcid.org/0000-0002-4834-6719.
   PubMedGoogle Scholar
• Horne, R., Weinman, J., Barber, N., Elliott, R., Morgan, M., Cribb, A., & Kellar, I. (2005). Concordance, adherence and compliance in medicine taking. London: NCCSDO, 2005(40), 6.
   Google Scholar
• Horne, R., Weinman, J., & Hankins, M. (1999). The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health, 14(1), 1–24. https://doi.org/10.1080/08870449908407311
   Web of Science ®Google Scholar
• Ideguchi, H., Ohno, S., & Ishigatsubo, Y. (2007). Risk factors associated with the cumulative survival of low-dose methotrexate in 273 Japanese patients with rheumatoid arthritis. Journal of Clinical Rheumatology, 13(2), 73–78. https://doi.org/10.1097/01.rhu.0000260526.29331.a8
   PubMed Web of Science ®Google Scholar
• Imran, M. Y., Khan, E. A. S., Ahmad, N. M., Raja, S. F., Saeed, M. A., & Haider, I. I. (1969). Depression in rheumatoid arthritis and its relation to disease activity. Pakistan Journal of Medical Sciences, 31(2), 393. https://doi.org/10.12669/pjms.312.6589
   Google Scholar
• Innes, J., Jamieson, T., Dales, R., & Lloyd, R. (2022). National quality improvement intervention to reduce high risk oral methotrexate prescribing. BMJ Open Quality, 11(3), e001942. https://doi.org/10.1136/bmjoq-2022-001942
   PubMedGoogle Scholar
• Ji, J., Zhang, L., Zhang, Q., Yin, R., Fu, T., Li, L., & Gu, Z. (2017). Functional disability associated with disease and quality-of-life parameters in Chinese patients with rheumatoid arthritis. Health and Quality of Life Outcomes, 15(1), 1–7. https://doi.org/10.1186/s12955-016-0578-4
   PubMedGoogle Scholar
• Karpouzas, G. A., Dolatabadi, S., Moran, R., Li, N., Nicassio, P. M., & Weisman, M. H. (2012). Correlates and predictors of disability in vulnerable US Hispanics with rheumatoid arthritis. Arthritis Care & Research, 64(9), 1274–1281. https://doi.org/10.1002/acr.21689
   Web of Science ®Google Scholar
• Ko, K. M., Moon, S.-J., Koh, J. H., Pae, C.-U., & Min, J.-K. (2020). Contribution of personality traits: Psychological factors, and health-related quality of life to medication adherence in patients with rheumatoid arthritis. Yonsei Medical Journal, 61(5), 406. https://doi.org/10.3349/ymj.2020.61.5.406
   PubMed Web of Science ®Google Scholar
• Kosinski, M., Kujawski, S. C., Martin, R., Wanke, L. A., Buatti, M. C., Ware, J. E., & Perfetto, E. M. (2002). Health-related quality of life in early rheumatoid arthritis: Impact of disease and treatment response. American Journal of Managed Care, 8(3), 231–242.
   PubMed Web of Science ®Google Scholar
• Kremer, J. M., & Phelps, C. T. (1992). Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Arthritis & Rheumatism, 35(2), 138–145. https://doi.org/10.1002/art.1780350203
   PubMed Web of Science ®Google Scholar
• Malik, F., & Ranganathan, P. (2013). Methotrexate pharmacogenetics in rheumatoid arthritis: A status report. Pharmacogenomics, 14(3), 305–314. https://doi.org/10.2217/pgs.12.214
   PubMed Web of Science ®Google Scholar
• Mary, A., Boursier, A., Desailly Henry, I., Grados, F., Séjourné, A., Salomon, S., Fardellone, P., Brazier, M., & Goëb, V. (2019). Mobile phone text messages and effect on treatment adherence in patients taking methotrexate for rheumatoid arthritis: A randomized pilot study. Arthritis Care & Research, 71(10), 1344–1352. https://doi.org/10.1002/acr.23750
   Web of Science ®Google Scholar
• Müller, R., Kallikorm, R., Põlluste, K., & Lember, M. (2012). Compliance with treatment of rheumatoid arthritis. Rheumatology International, 32(10), 3131–3135. https://doi.org/10.1007/s00296-011-2162-x
   PubMed Web of Science ®Google Scholar
• Overman, C. L., Bossema, E. R., van Middendorp, H., Wijngaards-de Meij, L., Verstappen, S. M., Bulder, M., Jacobs, J. W., Bijlsma, J. W., & Geenen, R. (2012). The prospective association between psychological distress and disease activity in rheumatoid arthritis: A multilevel regression analysis. Annals of the Rheumatic Diseases, 71(2), 192–197. https://doi.org/10.1136/annrheumdis-2011-200338
   PubMed Web of Science ®Google Scholar
• Park, D. C., Hertzog, C., Leventhal, H., Morrell, R. W., Leventhal, E., Birchmore, D., … Bennett, J. (1999). Medication adherence in rheumatoid arthritis patients: Older is wiser. Journal of the American Geriatrics Society, 47(2), 172–183. https://doi.org/10.1111/j.1532-5415.1999.tb04575.x
   PubMed Web of Science ®Google Scholar
• Pascual-Ramos, V., Contreras-Yáñez, I., Villa, A. R., Cabiedes, J., & Rull-Gabayet, M. (2009). Medication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: Associated factors and relationship with disease activity and with disability. Arthritis Research & Therapy, 11(1), R26–R11. https://doi.org/10.1186/ar2620
   PubMed Web of Science ®Google Scholar
• Pasma, A., van't Spijker, A., Hazes, J. M., Busschbach, J. J., & Luime, J. J. (2013). Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: a systematic review. Seminars in Arthritis and Rheumatism, 43(1), 18–28. https://doi.org/10.1016/j.semarthrit.2012.12.001
   Google Scholar
• Pincus, T., Callahan, L. F., Brooks, R. H., Fuchs, H. A., Olsen, N. J., & Kaye, J. J. (1989). Self-report questionnaire scores in rheumatoid arthritis compared with traditional physical,: radiographic, and laboratory measures. Annals of Internal Medicine, 110(4), 259–266. https://doi.org/10.7326/0003-4819-110-4-259
   PubMed Web of Science ®Google Scholar
• Ragab, O. M., Zayed, H. S., Abdelaleem, E. A., & Girgis, A. E. (2017). Effect of early treatment with disease-modifying anti-rheumatic drugs and treatment adherence on disease outcome in rheumatoid arthritis patients. The Egyptian Rheumatologist, 39(2), 69–74. https://doi.org/10.1016/j.ejr.2016.11.004
   Google Scholar
• Rau, R., Schleusser, B., Herborn, G., & Karger, T. (1997). Long-term treatment of destructive rheumatoid arthritis with methotrexate. The Journal of Rheumatology, 24(10), 1881–1889.
   PubMed Web of Science ®Google Scholar
• Rauscher, V., Englbrecht, M., van der Heijde, D., Schett, G., & Hueber, A. J. (2015). High degree of nonadherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. The Journal of Rheumatology, 42(3), 386–390. https://doi.org/10.3899/jrheum.140982
   PubMed Web of Science ®Google Scholar
• Ruban, T., Jacob, B., Pope, J., Keystone, E., Bombardier, C., & Kuriya, B. (2016). The influence of age at disease onset on disease activity and disability: Results from the Ontario best practices research initiative. Clinical Rheumatology, 35(3), 759–763. https://doi.org/10.1007/s10067-015-3031-x
   PubMed Web of Science ®Google Scholar
• Sakr, B. R., Elfishawi, M. M., ElArousy, M. H., Hatw, A. K., AbdulKarim, A. N., Tammam, A. B., Kotp, A. N., Hamed, M. E., Genedy, I. E., Desouky, E. D. E., & Nawito, Z. O. (2018). Rheumatoid arthritis: A single-center Egyptian experience. Immunological Investigations, 47(3), 293–302. https://doi.org/10.1080/08820139.2018.1425700
   PubMed Web of Science ®Google Scholar
• Salaffi, F., Manganelli, P., Carotti, M., Subiaco, S., Lamanna, G., & Cervini, C. (1997). Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: Report of five cases and review of the literature. Clinical Rheumatology, 16(3), 296–304. https://doi.org/10.1007/BF02238967
   PubMed Web of Science ®Google Scholar
• Salt, E., & Frazier, S. K. (2010). Adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Orthopaedic Nursing, 29(4), 260–275. https://doi.org/10.1097/NOR.0b013e3181e5c2c9
   PubMed Web of Science ®Google Scholar
• Schnabel, A., Herlyn, K., Burchardi, C., Reinhold-Keller, E., & Gross, W. (1996). Long-term tolerability of methotrexate at doses exceeding 15 mg per week in rheumatoid arthritis. Rheumatology International, 15(5), 195–200. https://doi.org/10.1007/BF00290521
   PubMed Web of Science ®Google Scholar
• Schnabel, A., Reinhold-Keller, E., Willmann, V., & Gross, W. (1994). Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis. Rheumatology International, 14(1), 33–38. https://doi.org/10.1007/BF00302669
   PubMed Web of Science ®Google Scholar
• Sharma, S., Tandon, V. R., & Mahajan, A. (2015). A study evaluating adherence and compliance of anti-rheumatic drugs in women suffering from rheumatoid arthritis. Journal of Clinical and Diagnostic Research, 9(11), OC01. https://doi.org/10.7860/JCDR/2015/15806.6729
   PubMedGoogle Scholar
• Shea, B., Swinden, M. V., Ghogomu, E. T., Ortiz, Z., Katchamart, W., Rader, T., … Tugwell, P. (2014). Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database of Systematic Reviews(5). https://doi.org/10.1002/14651858.CD000951.pub2
   Web of Science ®Google Scholar
• Simón-Campos, J. A., & Padilla-Hernández, R. O. (2008). Correlation between C reactive protein and erythrosedimentation rate with rheumatoid arthritis disease activity. Revista Médica del Instituto Mexicano del Seguro Social, 46(6), 591–596.
   PubMedGoogle Scholar
• Simpson, R. J. (2006). Challenges for improving medication adherence. JAMA, 296(21), 2614–2616. https://doi.org/10.1001/jama.296.21.jed60074
   PubMed Web of Science ®Google Scholar
• Sokka, T., Kankainen, A., & Hannonen, P. (2000). Scores for functional disability in patients with rheumatoid arthritis are correlated at higher levels with pain scores than with radiographic scores. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, 43(2), 386–389. doi:10.1002/1529-0131(200002)43:2<386::AID-ANR19>3.0.CO;2-Z
   PubMed Web of Science ®Google Scholar
• Sowden, E., Hassan, W., Gooden, A., Jepson, B., Kausor, T., Shafait, I., … Teh, L.-S. (2012). Limited end-user knowledge of methotrexate despite patient education: An assessment of rheumatologic preventive practice and effectiveness. Journal of Clinical Rheumatology, 18(3), 130–133. https://doi.org/10.1097/RHU.0b013e31824e1e63
   PubMed Web of Science ®Google Scholar
• Suh, Y. S., Cheon, Y.-H., Kim, H.-O., Kim, R.-B., Park, K. S., Kim, S.-H., Lee, S.-G., Park, E.-K., Hur, J., & Lee, S.-I. (2018). Medication nonadherence in Korean patients with rheumatoid arthritis: The importance of belief about medication and illness perception. The Korean Journal of Internal Medicine, 33(1), 203. https://doi.org/10.3904/kjim.2015.383
   PubMed Web of Science ®Google Scholar
• Sutton, S., Kinmonth, A.-L., Hardeman, W., Hughes, D., Boase, S., Prevost, A. T., Kellar, I., Graffy, J., Griffin, S., & Farmer, A. (2014). Does electronic monitoring influence adherence to medication? Randomized controlled trial of measurement reactivity. Annals of Behavioral Medicine, 48(3), 293–299. https://doi.org/10.1007/s12160-014-9595-x
   PubMed Web of Science ®Google Scholar
• Tuncay, R., Eksioglu, E., Cakir, B., Gurcay, E., & Cakci, A. (2007). Factors affecting drug treatment compliance in patients with rheumatoid arthritis. Rheumatology International, 27(8), 743–746. https://doi.org/10.1007/s00296-006-0299-9
   PubMed Web of Science ®Google Scholar
• Van Den Bemt, B. J., Zwikker, H. E., & Van Den Ende, C. H. (2012). Medication adherence in patients with rheumatoid arthritis: A critical appraisal of the existing literature. Expert Review of Clinical Immunology, 8(4), 337–351. https://doi.org/10.1586/eci.12.23
   PubMed Web of Science ®Google Scholar
• van den Hoogen, F. H., Benraad, B., Hekster, Y. A., & van Lankveld, W. (2009). Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs. The Journal of rheumatology, 36(10), 2164–2170. https://doi.org/10.3899/jrheum.081204
   PubMed Web of Science ®Google Scholar
• Viller, F., Guillemin, F., Briancon, S., Moum, T., Suurmeijer, T., & van den Heuvel, W. (1999). Compliance to drug treatment of patients with rheumatoid arthritis: A 3 year longitudinal study. The Journal of rheumatology, 26(10), 2114–2122.
   PubMed Web of Science ®Google Scholar
• Visser, K., Katchamart, W., Loza, E., Martinez-Lopez, J. A., Salliot, C., Trudeau, J., Bombardier, C., Carmona, L., van der Heijde, D., Bijlsma, J. W. J., Boumpas, D. T., Canhao, H., Edwards, C. J., Hamuryudan, V., Kvien, T. K., Leeb, B. F., Martin-Mola, E. M., Mielants, H., Muller-Ladner, U., … Dougados, M. (2009). Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: Integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E initiative. Annals of the Rheumatic Diseases, 68(7), 1086–1093. https://doi.org/10.1136/ard.2008.094474
   PubMed Web of Science ®Google Scholar
• Wallman, J. K., Eriksson, J. K., Nilsson, J-Å, Olofsson, T., Kristensen, L.-E., Neovius, M., & Geborek, P. (2016). Costs in relation to disability: Disease activity, and health-related quality of life in rheumatoid arthritis: Observational data from southern Sweden. The Journal of Rheumatology, 43(7), 1292–1299. https://doi.org/10.3899/jrheum.150617
   PubMed Web of Science ®Google Scholar
• Welsing, P. M., Van Gestel, A. M., Swinkels, H. L., Kiemeney, L. A., & Van Riel, P. L. (2001). The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, 44(9), 2009–2017. doi:10.1002/1529-0131(200109)44:9<2009::AID-ART349>3.0.CO;2-L
   PubMed Web of Science ®Google Scholar
• Wong, M., & Mulherin, D. (2007). The influence of medication beliefs and other psychosocial factors on early discontinuation of disease-modifying anti-rheumatic drugs. Musculoskeletal Care, 5(3), 148–159. https://doi.org/10.1002/msc.107
   PubMedGoogle Scholar
• Zhao, S., Chen, Y., & Chen, H. (2015). Sociodemographic factors associated with functional disability in outpatients with rheumatoid arthritis in southwest China. Clinical Rheumatology, 34(5), 845–851. https://doi.org/10.1007/s10067-015-2896-z
   PubMed Web of Science ®Google Scholar